eric topol glp 1 New @Nature A quintuple [GLP-1 + 4 other] receptor agonist drug that exceeds effects of the dual receptor (GLP-1 and GIP, tirzepatide) in the experimental model vs diabetes and obesity (in case A Big Week for GLP-1
Pay in 4 interest-free payments of $6.51 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
![eric topol glp 1 New @Nature A quintuple [GLP-1 + 4 other] receptor agonist drug that exceeds effects of the dual receptor (GLP-1 and GIP, tirzepatide) in the experimental model vs diabetes and obesity (in case A Big Week for GLP-1](https://substackcdn.com/image/fetch/$s_!KYTy!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F3eb691b5-c9c4-4a78-8ef8-b9d6e502ef35_600x842.png)
![eric topol glp 1 New @Nature A quintuple [GLP-1 + 4 other] receptor agonist drug that exceeds effects of the dual receptor (GLP-1 and GIP, tirzepatide) in the experimental model vs diabetes and obesity (in case A Big Week for GLP-1](https://upload.wikimedia.org/wikipedia/commons/2/28/Eric_Topol_in_2026_A.jpg)
![eric topol glp 1 New @Nature A quintuple [GLP-1 + 4 other] receptor agonist drug that exceeds effects of the dual receptor (GLP-1 and GIP, tirzepatide) in the experimental model vs diabetes and obesity (in case A Big Week for GLP-1](https://i.ytimg.com/vi/WwoF62V1Lg0/hq720.jpg?sqp=-oaymwEhCK4FEIIDSFryq4qpAxMIARUAAAAAGAElAADIQj0AgKJD&rs=AOn4CLAG0Vb3CsA3ma0wwzyQS75Gai3Q-Q)









)












